These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 8920244)

  • 1. Antigen analogs as tools to study T-cell activation function and activation.
    Sette A; Alexander J; Snoke K; Grey HM
    Semin Immunol; 1996 Apr; 8(2):103-8. PubMed ID: 8920244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen analogs/MHC complexes as specific T cell receptor antagonists.
    Sette A; Alexander J; Ruppert J; Snoke K; Franco A; Ishioka G; Grey HM
    Annu Rev Immunol; 1994; 12():413-31. PubMed ID: 8011286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells.
    Frasca L; Del Porto P; Tuosto L; Marinari B; Scottà C; Carbonari M; Nicosia A; Piccolella E
    J Immunol; 1999 Jul; 163(2):650-8. PubMed ID: 10395654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring low affinity peptide/MHC class I ligands can mediate negative selection and T cell activation.
    Motyka B; Teh HS
    J Immunol; 1998 Jan; 160(1):77-86. PubMed ID: 9551958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degenerate recognition of T cell epitopes: impact of T cell receptor reserve and stability of peptide:MHC complexes.
    Ford ML; Evavold BD
    Mol Immunol; 2004 Feb; 40(14-15):1019-25. PubMed ID: 15036905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of cytotoxic T-lymphocyte activation by soluble CD8.
    Sewell AK; Gerth UC; Price DA; Purbhoo MA; Boulter JM; Gao GF; Bell JI; Phillips RE; Jakobsen BK
    Nat Med; 1999 Apr; 5(4):399-404. PubMed ID: 10202928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
    Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
    Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC and T cell development.
    Viret C; Janeway CA
    Rev Immunogenet; 1999; 1(1):91-104. PubMed ID: 11256575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of antigen-specific antibody production by TCR antagonist peptides in vivo.
    Toda M; Totsuka M; Furukawa S; Yokota K; Yoshioka T; Ametani A; Kaminogawa S
    Eur J Immunol; 2000 Feb; 30(2):403-14. PubMed ID: 10671195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study on mechanisms of thymic selection by intrathymic administration of antigenic peptides].
    Nishihori H
    Hokkaido Igaku Zasshi; 1997 Sep; 72(5):517-28. PubMed ID: 9363468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
    Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
    Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
    J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of intrathymic TCR engagement by partial agonist on selection events and peripheral T cell activation program.
    Auphan N; Simon AK; Asnagli H; Phillips RJ; Rincon M; Ghosh S; Flavell RA; Schmitt-Verhulst AM
    J Immunol; 1998 May; 160(10):4810-21. PubMed ID: 9590228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
    Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
    Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-peptide/MHC and TCR antagonism: physiological role and therapeutic potential.
    Vukmanović S; Santori FR
    Cell Immunol; 2005 Feb; 233(2):75-84. PubMed ID: 15950208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of supramolecular activation clusters on fresh ex vivo CD8+ T cells after engagement of the T cell antigen receptor and CD8 by antigen-presenting cells.
    Potter TA; Grebe K; Freiberg B; Kupfer A
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12624-9. PubMed ID: 11606747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limits to the differential avidity model of T cell selection in the thymus.
    Girao C; Hu Q; Sun J; Ashton-Rickardt PG
    J Immunol; 1997 Nov; 159(9):4205-11. PubMed ID: 9379014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.